MURAT KAVRUK, ESRA MENFAATLİ, ARTA ARMANİ
Ankara Üniversitesi Tıp Fakültesi Mecmuası - 2024;77(1):13-19
Objectives: The aim of this study is to assess the research and innovation status of artificial intelligence (AI) in health sciences with a special focus on different application areas in health sciences and start-ups companies. Materials and Methods: Here in, two different datasets were used for analysis. The Web of Science database was analyzed to examine the scientific and technological knowledge production of AI technology in the health sector in general and in predetermined application areas. Secondly, the database of the technological investment portal dealroom.co, which includes innovative start-up organizations that produce AI-based solutions in the field of digital therapeutics and healthtech, was investigated. Results: In terms of contribution to AI-related literature, the USA and China lead in AI-focused publications, while Germany (22.2%) and the USA (21%) have the most health-specific coverage. Italy, Canada and the England follow these countries respectively (13.8%). Türkiye’s rate was found to be 10.1%. On the other hand, the United Kingdom (n=24) and Israel (n=21) stand out in terms of AI-powered start-ups in the health sector. Türkiye stands in the top ten countries distributing to AI-powered health science research but has no companies in the same field. Conclusion: AI in healthcare is on the rise, driven by increased research and applications, especially during the coronavirus disease-2019 pandemic. Some health subtopics remain underexplored, but start-ups are making promising strides. Wider AI adoption in healthcare is expected as financial and regulatory challenges are addressed.
